ArticleJournal of clinical medicine2026

Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

Ezgi Çoban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.